Managed Care e-News
Oct. 21, 2014

Journal of Managed Care Medicine new website released

The Journal of Managed Care Medicine (JMCM) has released its new website at www.jmcmpub.org. The website features current issues, past issues, supplements and much more. Be sure to visit the website for updates on the latest topics in managed care medicine.

If you are interested in advertising on the website or in JMCM, please click here.

If you would like a free subscription to the Journal of Managed Care Medicine, click here and fill out the form.More

Fall Managed Care Forum 2014


The Fall Forum will feature the first Annual Innovation Awards for the NAMCP Medical Directors Institute, AAMCN and AAIHDS. If you are interested in applying for this award, please contact Katie Eads at keads@namcp.org or 804-527-1905 and we will send you an application.

The Fall Forum will be held Nov., 12-13, 2014 at the Bellagio Resort in Las Vegas, Nevada for medical directors, nurses and administrators.

The Forum features up-to-date, useful information on the ACA and healthcare changes, trends and how to improve patient outcomes.

Click here to see the agenda, speakers, register and for more information on the conference.More

Why are healthcare workers getting infected with Ebola? We were not prepared
By Joan Spitrey
Thomas Eric Duncan, the first Ebola patient diagnosed in the United States, died Oct. 8. Shortly after, a nurse named Nina Pham was diagnosed with the Ebola virus, followed recently by a second nurse who is also infected. With the current infections of two direct caregivers, questions have surfaced regarding the preparedness of our hospitals and healthcare staff in the United States. Although the likelihood of any of us caring for an infected patient is slim, for the sake of our patients, our families and the public we must be educated and prepared.More

Why health insurance companies are doomed
Fortune
Massive political contributions notwithstanding, competition among health systems and pressure to reduce costs will put an end to health insurers as we know them. It’s that time of the year. No, not Halloween, but something almost as scary — open enrollment season. It’s time to choose among the many plans offered through the various health exchanges as part of Obamacare, among the variety of Medicare Advantage and prescription drug plans offered by private insurers as part of Medicare, and, for the 62 percent of employees who are have the opportunity, time to sign up for an employer-sponsored health insurance plan.More

PPACA initiative will give $114M in upfront investments to ACOs
Becker's Hospital Review
CMS has announced a new initiative available to Medicare Shared Saving Program accountable care organization that will provide upfront investments in infrastructure and redesigned care process to help ACOs provide high-quality care. The initiative, called the ACO Investment Model, will provide up to $114 million in upfront investments to as many as 75 ACOs.More

CMS to invest $114 million to boost rural ACOs
FierceHealthIT
The Centers for Medicare & Medicaid Services is making $114 million available to encourage Accountable Care Organizations in rural and underserved areas to take on greater financial risk. Seventy-five ACOs participating in the Medicare Shared Savings Program will be awarded the upfront investment through the ACO Investment Model, according to an announcement.More

FDA panel unanimously backs Novartis' psoriasis drug
Reuters
An advisory panel to the U.S. Food and Drug Administration unanimously recommended the use of Novartis AG's anti-inflammation drug in patients with a type of psoriasis, paving the way for its approval. The panel voted 7-0 in favor of the drug's use in plaque-psoriasis, the most common form of the painful, unsightly skin condition.More

Chimerix gets FDA OK to test drug for Ebola
The Associated Press via USA Today
A North Carolina drug maker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration. Chimerix said that it has received FDA clearance to proceed with a trial examining the safety and effectiveness of its brincidofovir tablets in patients who have the virus. More

Where genes and genealogies diverge
Forbes
A little more than half way through her new book, The Invisible History of the Human Race: How DNA and History Shape Our Identities and Our Futures, Christine Kenneally writes, “I once read that the flow of genes through time is like a great river, and individual lives are just eddies in the stream."More

Whole-gene scan analyzes mystery illnesses in kids
NBC News
A new kind of genetic test that analyzes all of a person’s genes can provide a diagnosis about a quarter of the time for patients whose conditions have baffled doctors, scientists reported. And for young children with mysterious developmental delays, the test gives a diagnosis more than 40 percent of the time.More

Massive study reveals schizophrenia's genetic roots
Scientific American
Schizophrenia is a distressing disorder involving hallucinations, delusions, paranoia and agitation. It affects around one in 100 people in the U.S., with symptoms usually first appearing between the ages of 16 and 30. Its causes have long been debated, particularly regarding whether genetics plays a role. It is known to be highly heritable, but small sample sizes and other methodology hurdles stymied early attempts to discern a genetic link.More

Why are healthcare workers getting infected with Ebola? We were not prepared
By Joan Spitrey
Thomas Eric Duncan, the first Ebola patient diagnosed in the United States, died Oct. 8. Shortly after, a nurse named Nina Pham was diagnosed with the Ebola virus, followed recently by a second nurse who is also infected. More

CMS projects faster health spending growth over next decade
By Christina Thielst
The Office of the Actuary at the Centers for Medicare and Medicaid Services recently released new estimates from its analysis of American health spending in the coming decade. More

Lessons healthcare workers can learn from Ebola crisis in Dallas
By Joan Spitrey
As many are aware, the first travel-associated case of Ebola in the United States was confirmed on Sept. 30. More

Perils of drinking sugary soda: weight gain, cavities, shortened lifespan
The Dallas Morning News
Sodas have a lot of sugar and a lot of calories. Yeah yeah yeah, so what else is new? This report comes via the Washington Post, which in turn saw it in the American Journal of Public Health. For the study, scientists at several universities studied 5,309 U.S. adults who took part in the National Health and Nutrition Examination Survey from 1999 to 2002.More

Dallas Ebola watch clears 1st froup quarantined
ABC News
Nearly all of the people who were quarantined by the city of Dallas because they had contact with a patient who died of Ebola have completed the 21-day incubation watch period and have been cleared of the disease, a city official said today. Dallas City Administrator Clay Jenkins said this morning that 43 of the 48 people who was isolated because of contact with Ebola patient Thomas Eric Duncan are now free to leave their homes.More

Women beat breast cancer, create products for patients
USA Today
Treatment for breast cancer often means surgery, and women find their bodies irrevocably changed as a result. No one understands this better than a survivor herself. Here are four women, all breast cancer survivors, who created companies to meet the specific needs of a woman's body after breast cancer.More

DNA said to protect Hispanic women from breast cancer
The Wall Street Journal
A genetic trait protects many women of Latin American descent from breast cancer, researchers probing the ethnic biology of cancer said. If confirmed, the finding may lead to more effective genetic testing for women at risk, by helping to determine who most needs to take preventative measures. Breast cancer is the most common cause of cancer deaths among women.More

New test reduces trial-and-error process for mental health drugs
By Rachael Mattice
Picking up a prescription from the pharmacy always includes general warnings. When it comes to more complex medications that are used to treat mental health disorders — such as antidepressants or antipsychotics — a patient can expect a printout of warning labels with possible adverse effects that are dangerous and symptomatically worse than the condition being initially treated. Substantial advances have been made in the field of genomic medicine since the decoding of the human genome in 2001. One such advance is known as pharmacogenetic testing. More

Mental health issues put 34,500 on New York's no-guns list
The New York Times
A newly created database of New Yorkers deemed too mentally unstable to carry firearms has grown to roughly 34,500 names, a previously undisclosed figure that has raised concerns among some mental health advocates that too many people have been categorized as dangerous.More